4.59
-0.20
(-4.18%)
04/10/2026
Foghorn Therapeutics Inc. (FHTX)
Trading Data | |
| Close | 4.59 |
| Open | 4.78 |
| High | 4.78 |
| Low | 4.53 |
| Volume | 160,900 |
| Change | -0.20 |
| Change % | -4.18 |
| Avg Volume (20 Days) | 173,776 |
| 52 Week Range | 3.14 - 6.95 |
| Price vs 52 Week High | -33.96% |
| Price vs 52 Week Low | 46.18% |
| Range | -3.97 |
| Gap Up/Down | -0.09 |
| Beta | 3.0510 |
Volume | |
| Volume 1 Day Change | -89,080 |
| Volume 1 Day Change (%) | -59.02 |
| Avg Volume 1 Week | 163,743 |
| Avg Volume 20 Days | 173,776 |
Fundamentals | |
| Market Capitalization (Mln) | 256 |
| EBIDTA | 0 |
| PE Ratio | 0.0000 |
| PEG Ratio | 0.0000 |
| WallStreet Target Price | 27.50 |
| Book Value | 2.1860 |
| Earnings Per Share | |
| EPS Estimate Current Quarter | |
| EPS Estimate Next Quarter | |
| EPS Estimate Current Year | |
| EPS Estimate Next Year | |
| Diluted EPS (TTM) | |
| Revenues | |
| Profit Marging | |
| Operating Marging (TTM) | |
| Return on asset (TTM) | |
| Return on equity (TTM) | |
| Revenue TTM | |
| Revenue per share TTM | |
| Quarterly Revenue Growth (YOY) | |
| Quarterly Earnings Growth (YOY) | |
| Gross Profit (TTM) | |
| Dividends | |
| Dividend Share | 0.0000 |
| Dividend Yield | |
| Valuations | |
| Trailing PE | |
| Forward PE | |
| Price Sales (TTM) | |
| Price Book (MRQ) | |
| Revenue Enterprise Value | |
| EBITDA Enterprise Value | |
| Shares | |
| Shares Outstanding | |
| Shares Float | |
| Shares Short | |
| Shares Short (Prior Month) | |
| Shares Ratio | |
| Short Outstanding (%) | |
| Short Float (%) | |
| Insider (%) | |
| Institutions (%) | |